INTRODUCTION
Due to high prevalence of carcinogenic, cardiovascular and metabolic syndromeassociated disorders all over the world, growing scientific studies have been aimed to investigate various natural plant peptides in respect to prevention and treatment of the chronic diseases (Hernández- (Singh et al., 2014) . One of the most promising and potential anticancer candidate, which was first isolated in 1987 in Japan during the screening of protease inhibitors from soybean is peptide lunasin (Liu et al., 2014) . Besides anticancer activity, it has inherent antioxidative and anti-inflammatory effects that could contribute to its chemopreventive action, and it could also play a vital role in regulation of cholesterol biosynthesis in the body (Lule et al., 2015) . These various biological functions of the peptide have been clearly demonstrated both in in vitro and in vivo assays (Fernández-Tomé and Hernández-Ledesma, 2016).
LUNASIN STRUCTURE
Lunasin (from the Tagalog word "lunas" for cure; Hernández-Ledesma and de Lumen, 2008) has been described as 43 amino acid peptide with a molecular weight of 5.5 kDa (Liu et Figure 1 . In summary, the peptide is composed of four regions: (I) fragment with unknown functions, (II) a predicted helix with structural homology to a conserved region of chromatin binding protein for binding to histones H3/H4, (III) a cell adhesion motif containing arginine (Arg), glycine (Gly) and aspartic acid (Asp) residues called RGD module, and (IV) a critical fragment with antimitotic functions consisting of eight aspartic acids at the C-terminus ( There is accumulating evidence that the last three functional fragments of the peptide are highly responsible for lunasin specific properties. The RGD tripeptide functions as an extracellular matrix to promote the intracellular accessibility of lunasin (Wan et al., 2017) . The important component of lunasin uptake appears to be mediate by internalization via the integrin recycling pathway, with the integrin αVβ3 being a key factor (Cam and de Mejia, 2012; Inaba et al., 2014; McConnell et al., 2015). However, it was shown that the role of RGD motif for cellular internalization is cell-line specific, required in C3H 10T1/2 mouse embryo fibroblasts cells (Galvez et al., 2001) but unnecessary in mouse fibroblast NIH3T3 cells (Lam et al., 2003) . Beyond this, the RGD motif potentiates the ability of lunasin to compete with integrins to bind with the extracellular matrix consequently suppressing the integrin-mediated signalling pathway, e.g., those that modulates proliferation, migration, invasion (Jiang et al., 2016) and apoptosis of the cells (Lu et al., 2006) . Antimitotic effect of lunasin has been attributed to the binding of its poly-D carboxyl end with high negatively charged 8 D-residues to regions of positively charged deacetyled histones and cellular regions, such as hypoacetylated chromatin found in telomeres and kinetochores in centromeres (Fernandéz-Tomé and Hernandéz-Ledesma, 2016). As a result, the kinetochore complex does not form properly, and the microtubules fail to
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HEALTH BENEFICIAL EFFECTS OF LUNASIN AND THEIR MOLECULAR MECHANISMS

Antioxidant activity
The antioxidant capacity of lunasin mediated through different mechanisms of action has been demonstrated on various in vitro cell models. In lipopolysaccharide (LPS)-stimulated RAW 264.7 macrophages, lunasin treatment led to a significant decreased production of reactive oxygen species (ROS) by the cells due to lunasin-induced inhibition of linoleic acid oxidation and 2,2'-azinobis (3-ethylbenzothiazo-line-6-sulfonic acid) diammonium salt (ABTS) radical scavenging activity of the peptide (Hernández-Ledesma et al., 2009b) . The authors hypothesize that the role of lunasin as linoleic acid oxidation inhibitor might be linked to its ability to react with peroxyl radicals resulting in suppression of the propagation cycle of lipid peroxidation. In the study by García-Nebot et al. (2014), the ability of lunasin to neutralize peroxyl and superoxide radicals in intestinal Caco-2 cells challenged by hydrogen peroxide and tert-buthylhydroxide has been proven. Additionally, protective effect of lunasin peptide purified from Solanum nigrum L. against DNA oxidative damage have been reported to be associated with suppressing the generation of hydroxyl radical followed by blocking fenton reaction between Fe 2+ and H2O2 by chelating iron ferrous ions (Jeong et al., 2010b) In these studies, the capability of lunasin or lunasin-like peptides to inhibit the production of proinflammatory cytokines and markers, such as tumor necrosis factor-α (TNF-α), interleukine-6 (IL-6), interleukine 1-β, cyclooxygenase-2, nuclear factor-kappa B (NF-κB), prostaglandin E, nitric oxide (NO) and others have been observed. The down-regulation of expression of the genes associated with uncontrolled and aberrant inflammation in the macrophages is mediated by lunasin-induced suppression of NF-κB pathways (de Mejia and Dia, 2009). The inhibition of Akt-mediated NF-κB activation was shown to be through potential interactions of lunasin with αVβ3 (Cam and de Mejia, 2012) and α5β1 integrins (Dia and de Mejia, 2011a). In addition to this, the mechanism of action by which lunasin or lunasin-like peptides exert their anti-inflammatory activities is based on the cell adhesion motif composed of RGD residues in their molecule structure that binds integrins with high specificity resulting in anti-inflammatory effects (Kuphal et  al., 2005) . Moreover, the alleviation of allergic airway inflammation symptoms manifested by markedly reduced Th2 cytokine expression, reduced inflammatory infiltration and cell metaplasia were found in 2 murine models with induced asthma after lunasin inhalation (Yang et al., 2015) . The observation suggests lunasin as an anti-inflammatory agent which can be potentially used in asthma therapy or as an adjuvant to enhance the efficacy of allergy immunotherapy.
Anticancer activity
Lunasin is primarily known as a bioactive peptide due to its ability to exhibit potential anticancer effects (Wan et al., 2017) . Chemoprotective properties of lunasin have been confirmed on various cell models in vitro, such as murine NIH/3T3 fibroblast cells (Lam et al., 2003) (Hsieh et al., 2010c) . The study by Jiang et al. (2016) have shown that the metastasis of breast cancer cells was suppressed by lunasin through integrin-mediated FAK/Akt/ERK and NF-κB signalling pathways followed by down-regulation of the activity and expression of matrix metalloproteinase-2/-9, possibly via competing with αVβ3 or αVβ5/α5β1 integrin. Human breast cancer MCF-7 cells treated with lunasin have been found to increase their expression and protein levels of the tumor suppressor phosphatase and tensin homolog PTEN, and to enhance PTEN nuclear localization leading to the induction of PTEN-mediated cellular apoptosis (Pabona et al., 2013) . Mechanistic studies using lunasin-sensitive NSCLC cell lines revealed the lunasin blocks cell cycle progression at the G1/S phase interface without inducing apoptosis (McConnell et al., 2015) . The authors found that lunasin altered the expression of the G1 specific cyclin-dependent kinase complex components, increased levels of p27Kip1, reduced levels of phosphorylated Akt, and ultimately inhibited the sequential phosphorylation of the retinoblastoma protein (RB). These effects are linked to the inhibition of integrin signalling through αV-containing integrins, strongly supporting the hypothesis that direct effects on integrin signalling represent a major mode of action responsible for lunasin's anticancer activity (Davis and Ianaba, 2016). In human metastatic colon KM12L4 cells, lunasin-arrested cell cycle in G2/M phase with concomitant increase in the expression of cyclin-dependent kinase inhibitors p21 and p27, and lunasin-induced mitochondrial pathway of apoptosis were reported (Dia and de Mejia, 2011b).
Hypocholesterolemic activity
Lunasin has also been previously proven to possess cholesterol lowering activity that is positively associated with cardiovascular system. The peptide exerts its action for lowering LDL cholesterol levels by directly inhibiting gene expression of 3-hydroxy-3-methylglutaryl coenzyme A (HMG Co-A) reductase to lower cholesterol biosynthesis and by increasing LDL receptor (LDLR) levels to enhance clearance of plasma LDL cholesterol (Galvez, 2012) . The underlying mechanism is related to lunasin's ability to bind specifically to histone H3 and to inhibit H3-Lys14 acetylation by the PCAF (acetyltransferase p300/CBP associated factor) histone acetylase enzyme. The acetylation of H3 by PCAF is required for transcriptional activation of HMG Co-A reductase, the rate-limiting enzyme for cholesterol biosynthesis in the liver. Therefore, lunasin significantly reduced HMG expression in HepG2 liver cells grown in cholesterol-free media by inhibiting PCAF acetylation of H3-Lys 14. Gu et al. (2017) have revealed two mechanisms by which lunasin increases cell-surface LDLR level and enhanced LDL uptake in HepG2 cells and ApoE -/-mice suggesting its potential role in cholesterol homeostasis maintenance. One of them is mediated via lunasininduced inhibition of proprotein convertase subtilisin/kexin type 9 (PCSK9) expression by down-regulating hepatocyte nuclear factor-1α (HNF-1α). Second one is attributed to PI3K/Akt-mediated activation of SREBP-2 pathway.
CONCLUSION
Epidemiologic studies indicate that bioactive compounds from plant resources have various biological functions with beneficial effect on health of living organisms. Many phytochemicals act in the prevention and/or treatment of numerous diseases such as cancer. Nowadays, peptides isolated from soya present the study subject of numerous research teams. Lunasin as one of these polypeptides has a specific amino acid sequence which ensures its unique properties. The substance is becoming an increasingly attractive molecule for research purposes mainly due to its biological availability in organism, its antioxidant, anti-inflammatory, anti-cancer and hypocholesterolemic effects potentially usable for therapeutic purposes. For that reason, there is a growing need for application of advanced molecular and proteomic tools to decipher molecular mechanisms of lunasin action in modulation of various diseases and to determine its safety and effectiveness. Cam, A., Savaguru, M., Gonzales de Mejia, E. (2013) . Endocytic mechanism of internalization of dietary peptide lunasin into macrophages in inflammatory condition associated with cardiovascular disease. PLoS One, 8(9) 
